ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS




Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN) Receives Positive CHMP Opinion For Use Of Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Advanced Colorectal Cancer 2/27/2015 9:33:46 AM
Amgen (AMGN) Announces The European Medicines Agency Acceptance Of Kyprolis (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma 2/27/2015 6:49:51 AM
Amgen (AMGN) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 9:35:04 AM
Amgen (AMGN)'s Hormone-Imbalance Drug AMG 416 Shows Positive Results in Phase 3 Study 2/26/2015 6:27:39 AM
Juno Therapeutics (JUNO) CEO and CFO Earn Hefty Bonuses; Poaches Ex-Amgen (AMGN), Dendreon (DNDN) Scientists 2/25/2015 6:12:58 AM
No, Amgen (AMGN), Sanofi (SAN.PA)'s New Cholesterol Drugs Aren't Going To Cost $150 Billion A Year 2/19/2015 6:41:51 AM
The Pink Slip Valentine: Companies Making Job Cuts: Sanofi (SAN.PA), InterMune (ITMN), Abbott (ABT), Syngenta AG (SYT), GlaxoSmithKline (GSK), Amgen (AMGN) 2/13/2015 4:22:58 AM
Amgen (AMGN) Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma 2/12/2015 6:08:31 AM
Amgen (AMGN)'s Melanoma Drug Talimogene Laherparepvec Lands a Date With the FDA 2/12/2015 6:07:45 AM
With the Help of Two Amgen (AMGN) Scientists, Ex-Dendreon (DNDN) CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle 2/6/2015 6:27:16 AM
12345678910...